세계의 다발성 경화증용 줄기세포 치료 시장 보고서(2025년)

Stem cell therapy for multiple sclerosis is a regenerative medical treatment that uses stem cells to repair nerve damage and restore immune system balance in individuals with multiple sclerosis, an autoimmune disease that attacks the myelin sheath protecting nerve fibers. The therapy aims to halt disease progression, reduce inflammation, and support the regeneration of damaged nervous tissue.

The main components of stem cell therapy for multiple sclerosis include embryonic stem cells, adult stem cells, induced pluripotent stem cells, mesenchymal stem cells, and hematopoietic stem cells. Stem cell therapy for multiple sclerosis using embryonic stem cells involves transplanting pluripotent cells derived from early-stage embryos to repair damaged myelin and promote neural regeneration. Treatment approaches include autologous stem cell therapy and allogeneic stem cell therapy. Delivery methods include intravenous injection, intrathecal injection, and direct intraspinal administration. Applications encompass relapsing-remitting multiple sclerosis (RRMS), primary progressive multiple sclerosis (PPMS), secondary progressive multiple sclerosis (SPMS), and progressive relapsing multiple sclerosis (PRMS). End users include hospitals, specialty clinics, research institutes, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The stem cell therapy for multiple sclerosis market research report is one of a series of new reports from The Business Research Company that provides stem cell therapy for multiple sclerosis market statistics, including stem cell therapy for multiple sclerosis industry global market size, regional shares, competitors with a stem cell therapy for multiple sclerosis market share, detailed stem cell therapy for multiple sclerosis market segments, market trends and opportunities, and any further data you may need to thrive in the stem cell therapy for multiple sclerosis industry. This stem cell therapy for multiple sclerosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The stem cell therapy for multiple sclerosis market size has grown rapidly in recent years. It will grow from $1.62 billion in 2024 to $1.82 billion in 2025 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be linked to increasing demand for regenerative medicine, a rising prevalence of multiple sclerosis, growing awareness of stem cell therapies, increasing investment in stem cell research, and improving clinical outcomes demonstrating the effectiveness of stem cell therapy.

The stem cell therapy for multiple sclerosis market size is expected to see rapid growth in the next few years. It will grow to $2.89 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be driven by rising demand for personalized medicine, growing patient preference for minimally invasive treatments, the expansion of regenerative therapy centers, increasing insurance coverage for advanced treatments, and strengthening collaborations between biotech companies and research institutions. Major trends in the forecast period include technological advancements in stem cell delivery methods, progress in gene editing and regenerative techniques, innovations in immunomodulatory therapies, increased research and development investment for novel treatments, and advancements in biomaterials supporting cell therapy.

The growing prevalence of multiple sclerosis (MS) is expected to significantly contribute to the expansion of the stem cell therapy market for multiple sclerosis in the future. Multiple sclerosis is a chronic autoimmune condition that affects the central nervous system by damaging the protective myelin sheath around nerve fibers, leading to disrupted communication between the brain and the body, and causing symptoms such as fatigue, muscle weakness, and vision problems. The rising number of MS cases is mainly due to advancements in diagnostic techniques, as improvements in medical imaging and increased awareness allow for more accurate and earlier detection, resulting in a higher number of reported cases. Stem cell therapy for multiple sclerosis helps repair damaged myelin, modulate abnormal immune responses, and encourage nerve cell regeneration, potentially reducing symptoms and slowing disease progression. For example, in May 2024, the MS Trust, a UK-based organization, published a report stating that approximately 2.9 million people worldwide are affected by multiple sclerosis, with over 150,000 individuals in the UK living with the condition. Therefore, the increasing prevalence of multiple sclerosis is expected to drive the growth of the stem cell therapy market for multiple sclerosis.

Leading companies in the stem cell therapy for multiple sclerosis market are focusing on developing innovative treatments, such as adipose-derived mesenchymal stem cells, to improve the efficacy, safety, and regenerative potential of therapies for patients with relapsing-remitting and progressive forms of multiple sclerosis. Adipose-derived mesenchymal stem cells (ADMSCs) are multipotent stem cells obtained from adipose (fat) tissue that can differentiate into various cell types and possess regenerative and immunomodulatory properties that are beneficial in treating autoimmune and neurodegenerative diseases like multiple sclerosis. For instance, in August 2025, Hope Biosciences, LLC, a U.S.-based biopharmaceutical company, introduced its HB-adMSCs therapy, which uses adipose-derived mesenchymal stem cells administered via high-dose infusions and repeat dosing over a 32-week period. The therapy combines immunomodulatory and neuroregenerative mechanisms, offering the potential to slow disease progression and repair myelin damage, setting it apart from conventional immunosuppressive treatments.

In November 2024, Pluri Inc., an Israel-based biotechnology company, partnered with Brainstorm Cell Therapeutics Ltd. Through this collaboration, Pluri Inc. aims to advance the development and commercialization of innovative regenerative therapies in partnership with Brainstorm Cell Therapeutics, combining their expertise to accelerate clinical research and improve treatment outcomes for patients. Brainstorm Cell Therapeutics Ltd. is a U.S.-based biotechnology company that specializes in stem cell therapy for multiple sclerosis.

Major companies operating in the stem cell therapy for multiple sclerosis market are Sana Biotechnology Inc., Century Therapeutics Inc., Reelabs Private Limited, PlacidWay LLC, MedAccess Guarantee Ltd, Celltex Therapeutics Corporation, CELLTEX THERAPEUTICS CORP, BrainStorm Cell Therapeutics Ltd., Athersys Inc., Advancells Dermaceuticals Private Limited, ImStem Biotechnology Inc., NeuroGenesis Bio Inc., Stem Cell Medicine Ltd., Biotherapy International, R3 Stem Cell, Hope Biosciences LLC, FibroBiologics Inc., Global Institute of Stem Cell Therapy and Research Inc., ProgenCell, Stemwell

North America was the largest region in the stem cell therapy for multiple sclerosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in stem cell therapy for multiple sclerosis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the stem cell therapy for multiple sclerosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The stem cell therapy for multiple sclerosis market includes revenues earned by providing services such as stem cell collection and processing services, cryopreservation and storage services, patient preconditioning services, post-therapy rehabilitation services, and immune system profiling services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Stem Cell Therapy For Multiple Sclerosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on stem cell therapy for multiple sclerosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for stem cell therapy for multiple sclerosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The stem cell therapy for multiple sclerosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type Of Stem Cell: Embryonic Stem Cells; Adult Stem Cells; Induced Pluripotent Stem Cells; Mesenchymal Stem Cells; Hematopoietic Stem Cells
• 2) By Treatment Approach: Autologous Stem Cell Therapy; Allogeneic Stem Cell Therapy
• 3) By Delivery Method: Intravenous Injection; Intrathecal Injection; Direct Intraspinal Administration
• 4) By Application: Relapsing-Remitting Multiple Sclerosis (RRMS); Primary Progressive Multiple Sclerosis (PPMS); Secondary Progressive Multiple Sclerosis (SPMS); Progressive Relapsing Multiple Sclerosis (PRMS)
• 5) By End-User: Hospitals; Specialty Clinics; Research Institutes; Other End-Users
• Subsegments:
• 1) By Embryonic Stem Cells: Inner Cell Mass Cells; Blastocyst Derived Cells; Totipotent Stem Cells
• 2) By Adult Stem Cells: Bone Marrow Stem Cells; Neural Stem Cells; Tissue Specific Stem Cells
• 3) By Induced Pluripotent Stem Cells: Reprogrammed Somatic Cells; Patient Derived Cells
• 4) By Mesenchymal Stem Cells: Adipose Derived Stem Cells; Umbilical Cord Derived Stem Cells; Bone Marrow Derived Stem Cells
• 5) By Hematopoietic Stem Cells: Peripheral Blood Stem Cells; Bone Marrow Stem Cells; Umbilical Cord Blood Stem Cells
• Companies Mentioned: Sana Biotechnology Inc.; Century Therapeutics Inc.; Reelabs Private Limited; PlacidWay LLC; MedAccess Guarantee Ltd; Celltex Therapeutics Corporation; CELLTEX THERAPEUTICS CORP; BrainStorm Cell Therapeutics Ltd.; Athersys Inc.; Advancells Dermaceuticals Private Limited; ImStem Biotechnology Inc.; NeuroGenesis Bio Inc.; Stem Cell Medicine Ltd.; Biotherapy International; R3 Stem Cell; Hope Biosciences LLC; FibroBiologics Inc.; Global Institute of Stem Cell Therapy and Research Inc.; ProgenCell; Stemwell
• Countries:

Table of Contents

1. Executive Summary

2. Stem Cell Therapy For Multiple Sclerosis Market Characteristics

3. Stem Cell Therapy For Multiple Sclerosis Market Trends And Strategies

4. Stem Cell Therapy For Multiple Sclerosis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Stem Cell Therapy For Multiple Sclerosis Growth Analysis And Strategic Analysis Framework

• 5.1. Global Stem Cell Therapy For Multiple Sclerosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Stem Cell Therapy For Multiple Sclerosis Market Growth Rate Analysis
• 5.4. Global Stem Cell Therapy For Multiple Sclerosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Stem Cell Therapy For Multiple Sclerosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Stem Cell Therapy For Multiple Sclerosis Total Addressable Market (TAM)

6. Stem Cell Therapy For Multiple Sclerosis Market Segmentation

• 6.1. Global Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Embryonic Stem Cells
• Adult Stem Cells
• Induced Pluripotent Stem Cells
• Mesenchymal Stem Cells
• Hematopoietic Stem Cells
• 6.2. Global Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Autologous Stem Cell Therapy
• Allogeneic Stem Cell Therapy
• 6.3. Global Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intravenous Injection
• Intrathecal Injection
• Direct Intraspinal Administration
• 6.4. Global Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Relapsing-Remitting Multiple Sclerosis (RRMS)
• Primary Progressive Multiple Sclerosis (PPMS)
• Secondary Progressive Multiple Sclerosis (SPMS)
• Progressive Relapsing Multiple Sclerosis (PRMS)
• 6.5. Global Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Research Institutes
• Other End-Users
• 6.6. Global Stem Cell Therapy For Multiple Sclerosis Market, Sub-Segmentation Of Embryonic Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inner Cell Mass Cells
• Blastocyst Derived Cells
• Totipotent Stem Cells
• 6.7. Global Stem Cell Therapy For Multiple Sclerosis Market, Sub-Segmentation Of Adult Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bone Marrow Stem Cells
• Neural Stem Cells
• Tissue Specific Stem Cells
• 6.8. Global Stem Cell Therapy For Multiple Sclerosis Market, Sub-Segmentation Of Induced Pluripotent Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reprogrammed Somatic Cells
• Patient Derived Cells
• 6.9. Global Stem Cell Therapy For Multiple Sclerosis Market, Sub-Segmentation Of Mesenchymal Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Adipose Derived Stem Cells
• Umbilical Cord Derived Stem Cells
• Bone Marrow Derived Stem Cells
• 6.10. Global Stem Cell Therapy For Multiple Sclerosis Market, Sub-Segmentation Of Hematopoietic Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Peripheral Blood Stem Cells
• Bone Marrow Stem Cells
• Umbilical Cord Blood Stem Cells

7. Stem Cell Therapy For Multiple Sclerosis Market Regional And Country Analysis

• 7.1. Global Stem Cell Therapy For Multiple Sclerosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Stem Cell Therapy For Multiple Sclerosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Stem Cell Therapy For Multiple Sclerosis Market

• 8.1. Asia-Pacific Stem Cell Therapy For Multiple Sclerosis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Stem Cell Therapy For Multiple Sclerosis Market

• 9.1. China Stem Cell Therapy For Multiple Sclerosis Market Overview
• 9.2. China Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Stem Cell Therapy For Multiple Sclerosis Market

• 10.1. India Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Stem Cell Therapy For Multiple Sclerosis Market

• 11.1. Japan Stem Cell Therapy For Multiple Sclerosis Market Overview
• 11.2. Japan Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Stem Cell Therapy For Multiple Sclerosis Market

• 12.1. Australia Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Stem Cell Therapy For Multiple Sclerosis Market

• 13.1. Indonesia Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Stem Cell Therapy For Multiple Sclerosis Market

• 14.1. South Korea Stem Cell Therapy For Multiple Sclerosis Market Overview
• 14.2. South Korea Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Stem Cell Therapy For Multiple Sclerosis Market

• 15.1. Western Europe Stem Cell Therapy For Multiple Sclerosis Market Overview
• 15.2. Western Europe Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Stem Cell Therapy For Multiple Sclerosis Market

• 16.1. UK Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Stem Cell Therapy For Multiple Sclerosis Market

• 17.1. Germany Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Stem Cell Therapy For Multiple Sclerosis Market

• 18.1. France Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Stem Cell Therapy For Multiple Sclerosis Market

• 19.1. Italy Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Stem Cell Therapy For Multiple Sclerosis Market

• 20.1. Spain Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Stem Cell Therapy For Multiple Sclerosis Market

• 21.1. Eastern Europe Stem Cell Therapy For Multiple Sclerosis Market Overview
• 21.2. Eastern Europe Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Stem Cell Therapy For Multiple Sclerosis Market

• 22.1. Russia Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Stem Cell Therapy For Multiple Sclerosis Market

• 23.1. North America Stem Cell Therapy For Multiple Sclerosis Market Overview
• 23.2. North America Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Stem Cell Therapy For Multiple Sclerosis Market

• 24.1. USA Stem Cell Therapy For Multiple Sclerosis Market Overview
• 24.2. USA Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Stem Cell Therapy For Multiple Sclerosis Market

• 25.1. Canada Stem Cell Therapy For Multiple Sclerosis Market Overview
• 25.2. Canada Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Stem Cell Therapy For Multiple Sclerosis Market

• 26.1. South America Stem Cell Therapy For Multiple Sclerosis Market Overview
• 26.2. South America Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Stem Cell Therapy For Multiple Sclerosis Market

• 27.1. Brazil Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Stem Cell Therapy For Multiple Sclerosis Market

• 28.1. Middle East Stem Cell Therapy For Multiple Sclerosis Market Overview
• 28.2. Middle East Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Stem Cell Therapy For Multiple Sclerosis Market

• 29.1. Africa Stem Cell Therapy For Multiple Sclerosis Market Overview
• 29.2. Africa Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Stem Cell Therapy For Multiple Sclerosis Market Competitive Landscape And Company Profiles

• 30.1. Stem Cell Therapy For Multiple Sclerosis Market Competitive Landscape
• 30.2. Stem Cell Therapy For Multiple Sclerosis Market Company Profiles
  • 30.2.1. Sana Biotechnology Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Century Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Reelabs Private Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. PlacidWay LLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. MedAccess Guarantee Ltd Overview, Products and Services, Strategy and Financial Analysis

31. Stem Cell Therapy For Multiple Sclerosis Market Other Major And Innovative Companies

• 31.1. Celltex Therapeutics Corporation
• 31.2. CELLTEX THERAPEUTICS CORP
• 31.3. BrainStorm Cell Therapeutics Ltd.
• 31.4. Athersys Inc.
• 31.5. Advancells Dermaceuticals Private Limited
• 31.6. ImStem Biotechnology Inc.
• 31.7. NeuroGenesis Bio Inc.
• 31.8. Stem Cell Medicine Ltd.
• 31.9. Biotherapy International
• 31.10. R3 Stem Cell
• 31.11. Hope Biosciences LLC
• 31.12. FibroBiologics Inc.
• 31.13. Global Institute of Stem Cell Therapy and Research Inc.
• 31.14. ProgenCell
• 31.15. Stemwell

32. Global Stem Cell Therapy For Multiple Sclerosis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Stem Cell Therapy For Multiple Sclerosis Market

34. Recent Developments In The Stem Cell Therapy For Multiple Sclerosis Market

35. Stem Cell Therapy For Multiple Sclerosis Market High Potential Countries, Segments and Strategies

• 35.1 Stem Cell Therapy For Multiple Sclerosis Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Stem Cell Therapy For Multiple Sclerosis Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Stem Cell Therapy For Multiple Sclerosis Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer